Liquid Biopsy Is an Early Cancer Screening Breakthrough Technology
Liquid biopsy is a groundbreaking, non-invasive method for early cancer detection and monitoring, offering significant clinical potential.
Liquid biopsy is a groundbreaking, non-invasive method for early cancer detection and monitoring, offering significant clinical potential.
A new high-sensitivity troponin test from Siemens can diagnose heart attacks but also predicts a patient’s risk of future cardiac events.
Octave Bioscience's study demonstrates that its clinically validated MSDA Test enhances decision-making in managing multiple sclerosis.
Consistency in quality control is critical to clinical lab performance. This guide outlines best practices that help labs reduce errors, ease staff burden, and maintain high standards—no matter the network size. Learn how to optimize QC workflows, leverage automation, and manage risk more effectively to improve patient outcomes and meet accreditation goals with confidence.
Despite limited progress in prognosis, recent advancements in molecular diagnostics is transforming diagnosis of cancer of unknown primary.